Altimmune Inc. Faces Class Action Lawsuit Over Alleged Securities Fraud Filed by Shareholders

Reuters
2025/10/01
Altimmune Inc. Faces Class Action Lawsuit Over Alleged Securities Fraud Filed by Shareholders

A class action lawsuit has been filed against Altimmune Inc., alleging securities fraud that affected investors between August 10, 2023, and June 25, 2025. The legal action claims that shareholders suffered financial losses due to misrepresentations or omissions by the company during this period. The suit seeks to recover damages on behalf of affected investors. The case is being handled by the law firm Levi & Korsinsky, which has a history of representing shareholders in securities litigation. Investors who incurred losses are encouraged to join the class action.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Altimmune Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1080289) on September 30, 2025, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10